Quick Answer
Revolution Medicines, Inc. reported Stockholders Equity of $1.63 billion for fiscal year 2025.
Revolution Medicines, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.63B | -28.0% |
| 2024 | $2.27B | +24.0% |
| 2023 | $1.83B | +166.5% |
| 2022 | $685.19M | +13.7% |
| 2021 | $602.57M | +26.9% |
| 2020 | $474.68M | +411.1% |
| 2019 | -$152.57M | -40.7% |
| 2018 | -$108.42M | -60.1% |
| 2017 | -$67.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.60B | +2.0% | -14.4% |
| June 30, 2025 | $1.87B | +15.2% | -10.2% |
| March 31, 2025 | $2.08B | +20.4% | -8.3% |
| December 31, 2024 | $2.27B | +24.0% | +44.6% |
| September 30, 2024 | $1.57B | +87.0% | -3.2% |
| June 30, 2024 | $1.62B | +73.9% | -6.2% |
| March 31, 2024 | $1.73B | +81.2% | -5.5% |
| December 31, 2023 | $1.83B | +166.5% | +118.1% |
- Revolution Medicines, Inc. showed a decrease of -28.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Revolution Medicines, Inc.’s stockholders equity has grown by 2509.0% (from -$67.72 million to $1.63 billion).
- The most recent figure is from Revolution Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: